292 related articles for article (PubMed ID: 31927946)
1. Stromal Modulation and Treatment of Metastatic Pancreatic Cancer with Local Intraperitoneal Triple miRNA/siRNA Nanotherapy.
Xie Y; Hang Y; Wang Y; Sleightholm R; Prajapati DR; Bader J; Yu A; Tang W; Jaramillo L; Li J; Singh RK; Oupický D
ACS Nano; 2020 Jan; 14(1):255-271. PubMed ID: 31927946
[TBL] [Abstract][Full Text] [Related]
2. Intraperitoneal siRNA Nanoparticles for Augmentation of Gemcitabine Efficacy in the Treatment of Pancreatic Cancer.
Tang S; Hang Y; Ding L; Tang W; Yu A; Zhang C; Sil D; Xie Y; Oupický D
Mol Pharm; 2021 Dec; 18(12):4448-4458. PubMed ID: 34699242
[TBL] [Abstract][Full Text] [Related]
3. Targeted nanodelivery of siRNA against KRAS G12D inhibits pancreatic cancer.
Huang R; Du H; Cheng L; Zhang P; Meng F; Zhong Z
Acta Biomater; 2023 Sep; 168():529-539. PubMed ID: 37451658
[TBL] [Abstract][Full Text] [Related]
4. Polyplex-mediated inhibition of chemokine receptor CXCR4 and chromatin-remodeling enzyme NCOA3 impedes pancreatic cancer progression and metastasis.
Wang Y; Kumar S; Rachagani S; Sajja BR; Xie Y; Hang Y; Jain M; Li J; Boska MD; Batra SK; Oupický D
Biomaterials; 2016 Sep; 101():108-120. PubMed ID: 27267632
[TBL] [Abstract][Full Text] [Related]
5. Polycation fluorination improves intraperitoneal siRNA delivery in metastatic pancreatic cancer.
Hang Y; Tang S; Tang W; Větvička D; Zhang C; Xie Y; Yu F; Yu A; Sil D; Li J; Singh RK; Oupický D
J Control Release; 2021 May; 333():139-150. PubMed ID: 33774121
[TBL] [Abstract][Full Text] [Related]
6. A Rationally Optimized Nanoparticle System for the Delivery of RNA Interference Therapeutics into Pancreatic Tumors in Vivo.
Teo J; McCarroll JA; Boyer C; Youkhana J; Sagnella SM; Duong HT; Liu J; Sharbeen G; Goldstein D; Davis TP; Kavallaris M; Phillips PA
Biomacromolecules; 2016 Jul; 17(7):2337-51. PubMed ID: 27305597
[TBL] [Abstract][Full Text] [Related]
7. Sequential Targeting TGF-β Signaling and KRAS Mutation Increases Therapeutic Efficacy in Pancreatic Cancer.
Pei Y; Chen L; Huang Y; Wang J; Feng J; Xu M; Chen Y; Song Q; Jiang G; Gu X; Zhang Q; Gao X; Chen J
Small; 2019 Jun; 15(24):e1900631. PubMed ID: 31033217
[TBL] [Abstract][Full Text] [Related]
8. Increased Survival by Pulmonary Treatment of Established Lung Metastases with Dual STAT3/CXCR4 Inhibition by siRNA Nanoemulsions.
Li Z; Chen G; Ding L; Wang Y; Zhu C; Wang K; Li J; Sun M; Oupicky D
Mol Ther; 2019 Dec; 27(12):2100-2110. PubMed ID: 31481310
[TBL] [Abstract][Full Text] [Related]
9. Endosomolytic and Tumor-Penetrating Mesoporous Silica Nanoparticles for siRNA/miRNA Combination Cancer Therapy.
Wang Y; Xie Y; Kilchrist KV; Li J; Duvall CL; Oupický D
ACS Appl Mater Interfaces; 2020 Jan; 12(4):4308-4322. PubMed ID: 31939276
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel tumor priming promotes delivery and transfection of intravenous lipid-siRNA in pancreatic tumors.
Wang J; Lu Z; Wang J; Cui M; Yeung BZ; Cole DJ; Wientjes MG; Au JL
J Control Release; 2015 Oct; 216():103-10. PubMed ID: 26272765
[TBL] [Abstract][Full Text] [Related]
11. Targeting of metastasis-promoting tumor-associated fibroblasts and modulation of pancreatic tumor-associated stroma with a carboxymethylcellulose-docetaxel nanoparticle.
Ernsting MJ; Hoang B; Lohse I; Undzys E; Cao P; Do T; Gill B; Pintilie M; Hedley D; Li SD
J Control Release; 2015 May; 206():122-30. PubMed ID: 25804872
[TBL] [Abstract][Full Text] [Related]
12. Cholangiocarcinoma therapy with nanoparticles that combine downregulation of MicroRNA-210 with inhibition of cancer cell invasiveness.
Xie Y; Wang Y; Li J; Hang Y; Jaramillo L; Wehrkamp CJ; Phillippi MA; Mohr AM; Chen Y; Talmon GA; Mott JL; Oupický D
Theranostics; 2018; 8(16):4305-4320. PubMed ID: 30214622
[TBL] [Abstract][Full Text] [Related]
13. Development of a Tumor-Responsive Nanopolyplex Targeting Pancreatic Cancer Cells and Stroma.
Li Y; Zhao Z; Liu H; Fetse JP; Jain A; Lin CY; Cheng K
ACS Appl Mater Interfaces; 2019 Dec; 11(49):45390-45403. PubMed ID: 31769963
[TBL] [Abstract][Full Text] [Related]
14. A self-assembled RNA-triple helix hydrogel drug delivery system targeting triple-negative breast cancer.
Ding L; Li J; Wu C; Yan F; Li X; Zhang S
J Mater Chem B; 2020 Apr; 8(16):3527-3533. PubMed ID: 31737891
[TBL] [Abstract][Full Text] [Related]
15. Effect of tocopherol conjugation on polycation-mediated siRNA delivery to orthotopic pancreatic tumors.
Tang S; Kapoor E; Ding L; Yu A; Tang W; Hang Y; Smith LM; Sil D; Oupický D
Biomater Adv; 2023 Feb; 145():213236. PubMed ID: 36512927
[TBL] [Abstract][Full Text] [Related]
16. Treatment of primary and metastatic breast and pancreatic tumors upon intravenous delivery of a PRDM14-specific chimeric siRNA/nanocarrier complex.
Taniguchi H; Natori Y; Miyagi Y; Hayashi K; Nagamura F; Kataoka K; Imai K
Int J Cancer; 2021 Aug; 149(3):646-656. PubMed ID: 33783816
[TBL] [Abstract][Full Text] [Related]
17. Dual Enzyme Cascade-Activated Popcorn-Like Nanoparticles Efficiently Remodeled Stellate Cells to Alleviate Pancreatic Desmoplasia.
Cao J; Wu J; Yang P; Qian K; Cheng Y; Xu M; Sheng D; Meng R; Wang T; Li Y; Wei Y; Zhang Q
ACS Nano; 2023 Oct; 17(20):19793-19809. PubMed ID: 37805928
[TBL] [Abstract][Full Text] [Related]
18. Reversibly Stabilized Polycation Nanoparticles for Combination Treatment of Early- and Late-Stage Metastatic Breast Cancer.
Chen G; Wang Y; Wu P; Zhou Y; Yu F; Zhu C; Li Z; Hang Y; Wang K; Li J; Sun M; Oupicky D
ACS Nano; 2018 Jul; 12(7):6620-6636. PubMed ID: 29985577
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide-induced stromal depletion for improved nanoparticle penetration in pancreatic cancer treatment.
Chen X; Jia F; Li Y; Deng Y; Huang Y; Liu W; Jin Q; Ji J
Biomaterials; 2020 Jul; 246():119999. PubMed ID: 32247201
[TBL] [Abstract][Full Text] [Related]
20. Suppression of CD51 in pancreatic stellate cells inhibits tumor growth by reducing stroma and altering tumor-stromal interaction in pancreatic cancer.
Horioka K; Ohuchida K; Sada M; Zheng B; Moriyama T; Fujita H; Manabe T; Ohtsuka T; Shimamoto M; Miyazaki T; Mizumoto K; Oda Y; Nakamura M
Int J Oncol; 2016 Apr; 48(4):1499-508. PubMed ID: 26846197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
